(Q41135353)

27 September 2017

Potent antitumour activity of a new class of tumour-specific killer cells (English)

1 reference

27 September 2017

Chen SY

1

1 reference

27 September 2017

Yang AG

2

1 reference

27 September 2017

Chen JD

3

1 reference

27 September 2017

Kute T

4

1 reference

27 September 2017

King CR

5

1 reference

27 September 2017

Collier J

6

1 reference

27 September 2017

Cong Y

7

1 reference

27 September 2017

Yao C

8

1 reference

27 September 2017

Huang XF

9

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

27 September 2017

1 reference

27 September 2017

385

1 reference

27 September 2017

78-80

1 reference

27 September 2017

6611

1 reference

https://scigraph.springernature.com/pub.10.1038/385078a0

27 September 2017

0 references

cites work

Redesigning nature's poisons to create anti-tumor reagents

1 reference

7 January 2021

Recombinant Toxins for Cancer Treatment

1 reference

7 January 2021

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

7 January 2021

Barriers to drug delivery in solid tumors

1 reference

7 January 2021

Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody

1 reference

7 January 2021

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

1 reference

7 January 2021

Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

1 reference

7 January 2021

Mechanism of protein translocation across the endoplasmic reticulum membrane

1 reference

7 January 2021

Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin

1 reference

7 January 2021

Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody

1 reference

7 January 2021

The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues.

1 reference

7 January 2021

The performance of e23(Fv)PEs, recombinant toxins targeting the erbB-2 protein

1 reference

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

7 January 2021

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

7 January 2021

Lymphocytes as cellular vehicles for gene therapy in mouse and man.

1 reference

7 January 2021

Factors involved in production of helper virus-free retrovirus vectors.

1 reference

7 January 2021

Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody

1 reference

7 January 2021

Identifiers

DOI

10.1038/385078A0

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference